Qualitative study of patients' decision-making when accepting second-line treatment after failure of first-line chemotherapy.
Jean-Louis PujolBenoît RochCaroline RothJean-Pierre MérelPublished in: PloS one (2018)
This study identified three domains involved into a complex interplay for lung cancer patients' decision regarding second-line palliative chemotherapy: (i) perception of the definitive loss of health, (ii) interactions between idiosyncrasy (hope, disease burden) and environment (healthcare and social network support), and (iii) patient's subjective evaluation of chemotherapy benefit-risk.